Soligenix Inc (SNGX)
0.4218
-0.01
(-1.22%)
USD |
NASDAQ |
Apr 26, 16:00
0.4218
0.00 (0.00%)
After-Hours: 20:00
Soligenix Enterprise Value: -0.6913M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | -0.6913M |
| April 24, 2024 | -1.154M |
| April 23, 2024 | -0.9755M |
| April 22, 2024 | -0.9144M |
| April 19, 2024 | -0.6492M |
| April 18, 2024 | -0.604M |
| April 17, 2024 | 0.1822M |
| April 16, 2024 | -0.2177M |
| April 15, 2024 | -0.2388M |
| April 12, 2024 | -1.122M |
| April 11, 2024 | -1.094M |
| April 10, 2024 | -0.3124M |
| April 09, 2024 | -0.2903M |
| April 08, 2024 | -0.0862M |
| April 05, 2024 | -0.223M |
| April 04, 2024 | -0.2377M |
| April 03, 2024 | -0.0788M |
| April 02, 2024 | 0.498M |
| April 01, 2024 | 0.7084M |
| March 28, 2024 | 1.129M |
| March 27, 2024 | 1.204M |
| March 26, 2024 | 1.024M |
| March 25, 2024 | 1.340M |
| March 22, 2024 | 1.496M |
| March 21, 2024 | 1.550M |
| Date | Value |
|---|---|
| March 20, 2024 | 1.396M |
| March 19, 2024 | 1.350M |
| March 18, 2024 | 1.235M |
| March 15, 2024 | 1.340M |
| March 14, 2024 | 1.517M |
| March 13, 2024 | 2.243M |
| March 12, 2024 | 2.287M |
| March 11, 2024 | 2.567M |
| March 08, 2024 | 2.885M |
| March 07, 2024 | 3.129M |
| March 06, 2024 | 3.068M |
| March 05, 2024 | 3.441M |
| March 04, 2024 | 3.234M |
| March 01, 2024 | 2.876M |
| February 29, 2024 | 2.487M |
| February 28, 2024 | 2.313M |
| February 27, 2024 | 2.498M |
| February 26, 2024 | 2.287M |
| February 23, 2024 | 2.887M |
| February 22, 2024 | 2.676M |
| February 21, 2024 | 2.445M |
| February 20, 2024 | 2.392M |
| February 16, 2024 | 2.066M |
| February 15, 2024 | 2.476M |
| February 14, 2024 | 2.144M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.008M
Minimum
Sep 01 2023
71.15M
Maximum
Dec 17 2020
20.19M
Average
16.78M
Median
Enterprise Value Benchmarks
| Eagle Pharmaceuticals Inc | -- |
| Marinus Pharmaceuticals Inc | 0.688M |
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.27M |
| iBio Inc | 15.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.820M |
| Total Expenses (Quarterly) | 2.132M |
| EPS Diluted (Quarterly) | -0.16 |
| Earnings Yield | -213.4% |
| Normalized Earnings Yield | -1135.25 |